Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

NCT04285515 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression
Major Depressive Disorder

Interventions

DRUG: Lumateperone
DRUG: Placebos

Sponsor

Intra-Cellular Therapies, Inc.